Treatment of ataxia and imbalance with varenicline (Chantix): Report of 2 patients with spinocerebellar ataxia (Types 3 and 14)

Clinical Neuropharmacology

Volumn 31, Issue 6, 2008, Pages 363-365

  Zesiewicz, Theresa A ^a,b   Sullivan, Kelly L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

4 2 nicotinic acetylcholine receptors balance; Chantix; Spinocerebellar ataxia; Varenicline

Indexed keywords

ATAXIN 14; ATAXIN 3; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; LORAZEPAM; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; VARENICLINE; ZOLPIDEM TARTRATE; BENZAZEPINE DERIVATIVE; QUINOXALINE DERIVATIVE;

ADULT; ARTICLE; BALANCE DISORDER; BRAIN ATROPHY; CASE REPORT; CEREBELLUM; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DYSARTHRIA; EVALUATION; FEMALE; GAIT DISORDER; GENETIC PROCEDURES; HUMAN; MINI MENTAL STATE EXAMINATION; NAUSEA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SMOKING CESSATION; SPINOCEREBELLAR DEGENERATION; SYMPTOM; DOSE RESPONSE; DRUG EFFECT; GAIT; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

BENZAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; MIDDLE AGED; QUINOXALINES; SPINOCEREBELLAR ATAXIAS; TREATMENT OUTCOME;

EID: 59849112382     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31818736a9     Document Type: Article

References (6)

1. Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66(11):1717-1720.
2. Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 2006;70(3):801-805.
3. Graham A, Court JA, Martin-Ruiz CM, et al. Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience 2002;113(3):493-507.
4. Al-Rejaie S, Dar MS. Behavioral interaction between nicotine and ethanol: possible modulation by mouse cerebellar glutamate. Alcohol Clin Exp Res 2006; 30(7):1223-1233.
5. Smith AD, Dar MS. Mouse cerebellar nicotinic-cholinergic receptor modulation of Delta9-THC ataxia: role of the alpha4beta2 subtype. Brain Res 2006;1115(1):16-25.
6. Chen WJ, Edwards RB, Romero RD, et al. Long-term nicotine exposure reduces Purkinje cell number in the adult rat cerebellar vermis. Neurotoxicol Teratol 2003;25(3):329-334.